GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » Total Equity

BCAX (Bicara Therapeutics) Total Equity : $491.88 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bicara Therapeutics Total Equity?

Bicara Therapeutics's total equity for the quarter that ended in Dec. 2024 was $491.88 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bicara Therapeutics Total Equity Historical Data

The historical data trend for Bicara Therapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bicara Therapeutics Total Equity Chart

Bicara Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Total Equity
-98.80 -148.77 491.88

Bicara Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial - -148.77 -174.78 509.56 491.88

Bicara Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bicara Therapeutics's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=509.996-18.121
=491.88

Bicara Therapeutics's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=509.996-18.121
=491.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bicara Therapeutics Total Equity Related Terms

Thank you for viewing the detailed overview of Bicara Therapeutics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bicara Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » Total Equity
Comparable Companies
FTRE COGT AVXL PRTA LENZ ABCL GHRS PRAX QURE ABUS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Website
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.